B1152

Betamethason-17,21-Dipropionat

• Synonym(e): 9α-Fluor-16β-methyl-11β,17α,21-trihydroxy-1,4-pregnadien-3,20-dion-17,21-dipropionat
• Empirische Formel (Hill-System): C₂₈H₃₇FO₇
• CAS-Nummer: 5593-20-4
• Molekulargewicht: 504.59
• EG-Nummer: 227-005-2
• MDL-Nummer: MFCD00133140
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 24891564
• NACRES: NA.77

Eigenschaften

• Assay: ≥97.0%
• Form: powder
• Ersteller: Schering Plough
• SMILES String: [H][C@@]12C[C@H](C)[C@](OC(=O)CCl)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)C3(F)[C@@]2([H])CCC4=CC(=O)C=C[C@]34C
• InChI: 1S/C27H34ClFO7/c1-5-22(33)35-14-21(32)27(36-23(34)13-28)15(2)10-19-18-7-6-16-11-17(30)8-9-24(16,3)26(18,29)20(31)12-25(19,27)4/h8-9,11,15,18-20,31H,5-7,10,12-14H2,1-4H3/t15-,18-,19-,20-,24-,25-,26?,27-/m0/s1
• InChIKey: UOCNBCVPZWLUKX-HOBFILNXSA-N

Beschreibung

Allgemeine Beschreibung

Betamethasone dipropionate is a class III intermediate potency synthetic fluorinated corticosteroid, which is used to treat psoriasis vulgaris. It is also used to treat seborrheic dermatitis and chronic hand eczema.

Biochem./physiol. Wirkung

Betamethason-17,21-dipropionat ist ein Glucocorticoid mit entzündungshemmender und immunsuppressiver Wirkung.

Leistungsmerkmale und Vorteile

This compound was developed by Schering Plough. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Sicherheitshinweise

• Piktogramme: GHS08
• Signalwort: Danger
• H-Sätze: H360FD,H373
• P-Sätze: P202 - P260 - P280 - P308 + P313 - P405 - P501
• Gefahreneinstufungen: Repr. 1B - STOT RE 2
• Zielorgane: Liver,Kidney,Endocrine system
• Lagerklassenschlüssel: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 2
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves, type N95 (US)